BJUI Mini Reviews - Improving Outcomes in Early Prostate Cancer: Part II – Neoadjuvant Treatment
In this article we review the current evidence that supports the use of neoadjuvant therapies as part of an integrated therapeutic approach to the treatment of ‘high-risk’ localized and locally advanced prostate cancer.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |
